January 08, 2025 04:13 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad
COVID-19: Dr. Reddy’s Laboratories announces commercial launch of 2DG

COVID-19: Dr. Reddy’s Laboratories announces commercial launch of 2DG

Jun 28, 2021, at 10:09 pm

Hyderabad: Dr. Reddy’s Laboratories Ltd. on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG).

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

DCGI approves DRDO's anti-COVID oral drug '2-DG' for emergency use

May 08, 2021, at 11:57 pm

New Delhi/IBNS: The Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.